IGG4-RELATED DISEASE
Clinical trials for IGG4-RELATED DISEASE explained in plain language.
Never miss a new study
Get alerted when new IGG4-RELATED DISEASE trials appear
Sign up with your email to follow new studies for IGG4-RELATED DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to shrink swollen glands in rare disease
Disease control OngoingThis study tests whether efgartigimod, a drug that lowers certain antibodies, can reduce swelling in the tear glands, saliva glands, or pancreas of people with IgG4-related disease. Five adults will receive weekly injections for 12 weeks and have regular scans and checkups. The g…
Matched conditions: IGG4-RELATED DISEASE
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New drug aims to stop Flare-Ups in rare autoimmune disease
Disease control OngoingThis study tests a drug called obexelimab to see if it can prevent flare-ups in people with IgG4-related disease, a rare condition where the immune system attacks the body's own tissues. About 194 adults with active disease will receive either the drug or a placebo. The main goal…
Matched conditions: IGG4-RELATED DISEASE
Phase: PHASE3 • Sponsor: Zenas BioPharma (USA), LLC • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug aims to stop Flare-Ups in rare autoimmune disease
Disease control OngoingThis study tests a drug called inebilizumab to see if it can prevent flare-ups in people with IgG4-related disease, a rare condition that causes swelling and damage in organs. About 135 adults who have had recent flare-ups are taking part. The main goal is to see how long it take…
Matched conditions: IGG4-RELATED DISEASE
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC